[Advantages and disadvantages of warfarin and pradaxa therapy for venous thromboembolism]
| Autor: | B S, Sukovatykh, L N, Belikov, O F, Savchuk, M B, Sukovatykh |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Ultrasonography Doppler Duplex Dose-Response Relationship Drug Drug Substitution Heparin Drug Administration Routes Anticoagulants Hemorrhage Venous Thromboembolism Middle Aged Severity of Illness Index Drug Administration Schedule Dabigatran Treatment Outcome Lower Extremity beta-Alanine Humans Benzimidazoles Female Warfarin Drug Monitoring Blood Coagulation Tomography Spiral Computed |
| Zdroj: | Vestnik khirurgii imeni I. I. Grekova. 173(4) |
| ISSN: | 0042-4625 |
| Popis: | An analysis of complex examination of 110 patients with venous thromboembolism was made. The patients were separated into 2 groups. The first group included 60 patients, who had the start heparin therapy during 7 days with the following 6-month warfarin therapy. Warfarin was substituted by pradaxa (dabigatran) for 50 patients of the second group. The efficacy of pradaxa could be compared with warfarin. However, pradaxa had a number of advantages such as the predictable anticoagulant effect, standard dosages. This medicine is more predictable and doesn't require a control of homeostasis and an adjustment of drug dosage. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|